LAKEWOOD, NJ, Jan. 05, 2026 (GLOBE NEWSWIRE) -- Reliance Global Group, Inc. (Nasdaq: RELI) (the “Company”) today announced the unanimous Board approval for its formation of EZRA International Group, a ...
Formation Bio has acquired the global rights, excluding in Greater China, to LNK01006, a highly selective tyrosine kinase 2 (TYK2) inhibitor from Lynk Pharmaceuticals. This next-generation central ...
International diabetes pioneers and thought leaders from 11 countries will work with Biomea leadership to unlock the potential of menin science and beta cell biology to advance BMF-219 and Biomea’s ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback